Christoph Heitmann

Papers

1

Total Citations

2

H-Index

1

About

Christoph Heitmann is a urologic researcher whose work centers on improving surgical outcomes and risk stratification for prostate cancer patients. His key research areas include the optimization of radical prostatectomy techniques, the role of extended pelvic lymph node dissection (ePLND), and the development of practical tools for preoperative risk assessment. Heitmann’s major contribution is the validation of a simple, questionnaire-based comorbidity index in a large cohort of over 5,000 consecutive patients undergoing radical prostatectomy. This work provides surgeons with an easily applicable method to better predict patient outcomes and tailor treatment decisions. Additionally, his investigations into robotic-assisted laparoscopic extended pelvic lymph node dissection (RALePLND) have clarified lymph node yield and distribution patterns, offering critical insights for improving staging accuracy in prostate cancer. While his most-cited paper has garnered 2 citations, the clinical relevance of his large-scale validation study and technical refinements in surgical oncology underscores his impact on evidence-based urologic practice.

Research Focus

Key Achievements

1
H-Index
1
Papers
2
Total Citations
2
Avg Citations/Paper
🏆 Most Cited Paper
PD40-07 VALIDATION OF AN EASILY APPLICABLE QUESTIONNAIRE-SUITED COMORBIDITY INDEX IN 5050 CONSECUTIVE PATIENTS UNDERGOING RADICAL PROSTATECTOMY
2 citations · 2019
📈 Most Prolific Year: 2019 (1 Papers)
🤝 Key Collaborators: 8

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago